Figure 6From: Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications IGF-I bioavailability (expressed as IGF-I/IGFBP-3 molar ratio) before and during rhGH therapy in the patients divided according to the thyroid function during the initial phase of rhGH administration.Back to article page